Synthetic membraneless organelles for biotechnology applications reviewed

Mar 10, 2026

A new review outlines design principles and applications of synthetic membraneless organelles built through liquid-liquid phase separation for use in biotechnology.

(Nanowerk News) Scientists have mapped out a detailed engineering framework for building synthetic membraneless organelles, compartments formed through liquid-liquid phase separation that can function as programmable microreactors inside living cells. A team led by Professor Wang Peng at the Hefei Institutes of Physical Science worked with international collaborators to produce a comprehensive review, now published in Synthetic and Systems Biotechnology (“Advances in engineering and applications of synthetic phase-separated membraneless organelles in biotechnology”), that lays out how these structures can be designed, assembled, and applied across a range of biotechnological fields.

Key Findings

Cells naturally use membraneless organelles to compartmentalize biochemical reactions without the need for lipid bilayer barriers. These structures arise through liquid-liquid phase separation, a physical process in which certain biomolecules spontaneously demix from their surroundings to form concentrated droplets. In recent years, researchers have begun engineering synthetic versions of these condensates to harness the same organizational principles for practical purposes. The review addresses the construction of synthetic membraneless organelles from three angles. First, it categorizes the types of scaffold molecules that can drive phase separation, including intrinsically disordered proteins, multivalent interaction domains, and nucleic acid-based scaffolds. Second, it examines strategies for recruiting specific client molecules into condensates to control their composition and function. Third, it surveys characterization techniques used to verify and measure the properties of these engineered compartments. Construction and applications of membraneless organelles. (Image: SUN Manman) On the application side, the authors describe how synthetic condensates can spatially concentrate enzymes and substrates to increase metabolic flux along engineered pathways. By organizing catalytic steps within membrane-free microreactors, researchers have achieved higher reaction efficiencies and more precise control over cellular outputs. The review documents successes in reprogramming metabolic networks, enhancing enzyme activity, regulating gene expression at the transcriptional and translational levels, and improving the yield and purification of recombinant proteins. “In recent years, LLPS-driven membraneless organelles have evolved from a biological curiosity into a practical engineering toolkit,” said Dr. Sun Manman, a member of the research team. “These programmable, membrane-free compartments enhance bioproduction efficiency, allow safer expression of toxic products, and create new opportunities for green manufacturing and precision medicine.” Beyond improving production yields, the review highlights the capacity of artificial membraneless organelles to reduce cytotoxicity associated with certain biosynthetic products. By sequestering toxic intermediates or end products within condensate compartments, cells can manufacture high-value compounds that would otherwise inhibit growth or trigger cell death. This capability could prove particularly relevant for the biosynthesis of pharmaceutical precursors and specialty chemicals that are difficult to produce using conventional expression systems. Looking ahead, the authors identify several technologies poised to push the field forward. Artificial intelligence-assisted protein design is enabling researchers to create novel scaffold molecules with tailored phase separation behavior. Advances in high-resolution imaging allow more detailed observation of condensate dynamics inside living cells, while high-throughput screening platforms accelerate the identification of optimal designs. Together, these tools are expected to yield phase-separated systems that are more stable, controllable, and orthogonal, meaning they can operate independently without interfering with native cellular processes. The research team envisions that continued progress in this area will provide foundational technology for next-generation programmable cell factories capable of producing complex molecules on demand. Functional biomaterials assembled through controlled phase separation and precision drug delivery platforms that exploit condensate properties also represent promising directions outlined in the review.